News
Discover our resources, including our company information and activities
Aquilon Pharma secures €6 million in refinancing to support the commercial launch of its nasal product line
This refinancing is based on four complementary and interdependent pillars: Thanks to this fundraising, the launch of the first medical...
Aquilon proves the high potential of HP-Betadex in Dry Powder formulation
The BioWin-funded Aeronext research project has reached its mid-term milestone, confirming the clinical and technological potential of HP-Betadex formulations for...
Aquilon and partners cross the mid-term milestone for Aeronext
Aquilon Pharma, together with its partners, recently reached an important milestone (the “go/no go milestone” on the research part) for...
Board reshuffle at Aquilon Pharmaceuticals
Following a decision, taken during the September Board meeting, Mr Paul Maes handed over the role of Executive Chairman to...
Contact us
Do you have a question? Let's get in touch.